Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Arelis

Melbourne start-up developing an at-home urine test with machine learning to screen for endometriosis.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Distribution 2
  • Co-development 1
  • Investors 1

Distribution2

A channel or customer base to reach together

Use Hormony’s pharmacy kit channel for at-home women’s-health tests

Hormony already sells an at-home hormone kit through the Mannings pharmacy chain, proving a retail route for FemTech kits. Once validated, Arelis' test could follow the same channel and Hormony could broaden its shelf to a second women's-health indication.

20%confidence

Evidence from the records

  • “women's health tests, starting with endometriosis screening from a simple urine sample that can be collected at home”
  • “Kit sold in Hong Kong through the Mannings pharmacy chain.”
If it works
A pre-agreed distribution path for launch, strengthening the seed pitch.
First step
Schedule a founder call with Hormony to learn the pharmacy listing process and terms.

Route screening through IKI’s women’s-health prescribers

IKI equips clinicians who prescribe personalised programmes, notably for menopause; the same prescribers see endometriosis patients. Adding Arelis' screen as an orderable test in IKI would give Arelis a European clinician channel and IKI a diagnostic entry point.

15%confidence

Evidence from the records

  • “notably for menopause”
  • “Professional subscriptions on sale on the website”
  • “Machine learning/AI analysis of a urine sample to build an endometriosis risk profile.”
If it works
A clinician-facing pilot in Spain after validation.
First step
Share a product brief with IKI Health and ask for 3 gynaecologist advisers among its users.

Co-development1

An integration or joint product

Source de-identified clinical data to train and validate the model

Arelis' main gap is clinical data; Cromodata runs a de-identified clinical-data marketplace across dozens of hospitals in five countries. A data partnership could accelerate model development and external validation, and give Cromodata a FemTech data buyer.

20%confidence

Evidence from the records

  • “No clinical data”
  • “Pipeline for de-identifying and standardizing fragmented clinical records”
  • “claimed network of 47 to 84+ healthcare facilities in 5 countries”
If it works
A retrospective validation dataset at lower cost than a de-novo study.
First step
Ask Cromodata whether its network holds gynaecology/endometriosis-coded records and the access price.

Investors1

A fund whose thesis fits

Join StartUp Health’s global pre-seed health portfolio

StartUp Health invests at pre-seed/seed in HealthTech globally and co-led network member Wink Biotherapeutics' pre-seed, offering a warm introduction. Its long-term ‘health moonshot’ format suits an R&D-stage diagnostic.

25%confidence

Evidence from the records

  • “StartUp Health, Dreamward Ventures”
  • “Too early to invest.”
If it works
Pre-seed capital and access to a health-founder community.
First step
Request an intro to StartUp Health from Wink Biotherapeutics' founders.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. BelliwithGolden Gate VenturesInvestors
    Pitch Series A to an Asia–Middle East early-stage VC

    Belli's revenue base sits exactly in Golden Gate's footprint: Singapore HQ, Southeast Asian carriers and Gulf flag carriers. Golden Gate invests Seed to Series A, the stage Belli is approaching, and already backed BioSapien in the network, which gives a warm founder-to-founder introduction.

    50%
  2. AstrolightwithSeraphim SpaceInvestors
    Series A from a specialist space investor

    Seraphim invests globally in space and deep tech addressing security and resilience, from Seed onwards, and appears among G-Space's investors in the network. Astrolight's dual-use optical links fit that thesis precisely.

    40%
  3. ChonexwithCavallo VenturesInvestors
    Bring an agri CVC into the Series A

    Cavallo Ventures is an agri-focused CVC investing from seed to Series B and backed network member ZymoChem. A strategic agri investor fits Chonex's $6M Series A and can accelerate distribution.

    40%
  4. CredncewithMicrotractionInvestors
    Pitch a pre-seed fund whose ticket matches the round

    Crednce is raising $175,000; Microtraction writes $0.1–0.35M pre-seed tickets in Africa with FinTech in its sectors and Ghana in its geographies. The ticket and stage fit are exact, which is rare for a pre-traction fintech.

    40%
  5. TerraSparkwithSeraphim SpaceInvestors
    Target Seraphim Space for the seed round

    Seraphim invests globally in space and climate deep tech from seed onward, with a resilience thesis that covers energy security. It backed network member G-Space, giving a warm path to a seed lead after the 2026 demonstration.

    40%
  6. Thistle OÜwithNATO DIANAInvestors
    Apply to NATO DIANA with the trial results

    NATO DIANA supports pre-seed and seed dual-use start-ups across Europe and North America, exactly Thistle's stage. Network member Astrolight is in the DIANA programme and can coach the application.

    40%
  7. VenditekwithInnogen Capital VenturesInvestors
    Raise from Innogen Capital via Pulster

    Innogen invests at pre-seed and seed in commerce and retail across El Salvador, Honduras, Guatemala and Latin America. It backed network member Pulster.ai, a warm path and a natural co-operation story.

    40%
  8. Wink BiotherapeuticswithU.S. National Institutes of Health (NIH)Investors
    Apply for NIH SBIR funding

    NIH funds US biotech and medtech via SBIR and backed network members Defined Bioscience, Corticale and Microvitality. Non-dilutive funding fits Wink's $75K capital base.

    40%
  9. General Ammonia Co.withU.S. Department of Energy (DOE)Investors
    Apply for DOE early-stage funding via the Sunchem path

    DOE funds pre-seed and seed climate and deep tech in the US, the natural first money for a lab-to-pilot electrochemistry project. DOE already supports network members Sunchem, ZymoChem and Enexor; Sunchem went through Cyclotron Road / DOE LEEP and can advise on the route.

    40%
  10. Neumic Therapeutics LtdwithIcehouse VenturesInvestors
    Seed round from New Zealand's early-stage investor

    Icehouse invests early in Kiwi founders and keeps backing them internationally, from pre-seed to later stages, and backed Neocrete in the network. A University of Otago spin-off with a Volpara co-founder is squarely in its remit.

    40%
  11. IKI HealthwithMutua Ventures (Mutua Madrileña)Investors
    Pitch Mutua Ventures on prevention for an insurer

    Mutua Ventures is the Spanish insurer-backed CVC investing in HealthTech in Spain and Europe and backed network member Legit.Health. A prevention platform with clinical data matches an insurer's interest in reducing claims.

    40%
  12. Piezo Sonic CorporationwithSBI InvestmentInvestors
    Pitch SBI Investment for a disclosed growth round

    SBI Investment's stated focus covers robotics and hardware at Series A and later in Japan and Asia, matching Piezo Sonic's stage and geography. SBI already backed network member Kauche, which gives a warm intro path inside Champions Network.

    40%
  13. Allergen AlertwithEuropean Innovation Council (EIC / EIC Fund)Investors
    EIC Accelerator for diagnostic deep tech

    The EIC Fund takes strategic risk on European breakthrough MedTech/deep tech from seed, with tickets from $0.55M. Allergen Alert's pre-commercial, hardware-heavy profile is exactly the funding gap it targets; network members Lampsy Health and Leitspalt are EIC-backed and can share application experience.

    35%
  14. AstromewithSeraphim SpaceInvestors
    Pitch Seraphim for the Series A

    Seraphim invests globally in space and deep tech for security and resilience from seed onward. It backed network member G-Space, giving a warm path as Astrome moves into satcom.

    35%
  15. TausiwithAntler East AfricaInvestors
    Pitch Antler East Africa for a pre-seed cheque

    Antler East Africa invests up to $0.1M at pre-seed in East Africa; the global Antler network backed network members ThirdRoc and aimea.ai.

    35%
  16. TerraSparkwithEuropean Innovation Council (EIC / EIC Fund)Investors
    Prepare an EIC Accelerator blended-finance bid

    The EIC Fund backs European breakthrough technologies in space and climate with tickets from €0.5M up to €33M, matching TerraSpark's capital intensity. Network members Leitspalt and Lampsy Health obtained EIC support and can share application know-how.

    35%
  17. Thistle OÜwithCoinvest CapitalInvestors
    Bring Coinvest Capital into the open round

    Coinvest is a Lithuanian pre-seed/seed fund investing in deep tech, robotics and AI across Europe, and it backed network member Astrolight, a dual-use company. A Baltic investor familiar with defence suits Thistle's open first round.

    35%
  18. TRL11withSeraphim SpaceInvestors
    Space-specialist investor for the next round

    Seraphim invests from Seed in space ventures addressing security and resilience globally and is listed among G-Space's investors in the network. TRL11's SSA and RPO imaging fits security-oriented space infrastructure.

    35%
  19. EvoNaturawithSOSVInvestors
    Pitch SOSV, ZymoChem's early backer

    SOSV backs deep tech for planetary health from pre-seed onwards and supported ZymoChem through IndieBio in the network.

    35%
  20. EVR Motors Ltd.withBorgWarnerInvestors
    Strategic investment from an EV drivetrain tier-1

    BorgWarner invests strategically in Mobility and Climate & energy and made a $10M strategic minority investment in Enexor in the network. A compact, low-rare-earth motor topology is directly relevant to a drivetrain supplier, and EVR's Series A is announced as under way.

    35%

Similar profiles

Compatibility score with Arelis

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.